FOS and intestinal neoplasm: In conventional C57BL/6J Min/+ mice, inulin has been reported to increase the genetically driven small intestinal tumor burden [56–58] except for one study reporting short chain FOS (which can be produced by degradation of inulin) to attenuate tumorigenesis [59].